Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.61 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
| ▸ | RAD52 | P43351 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10621483 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL335168 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL1206999 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL323128 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL7129437 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL5836729 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL11131653 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL6740298 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL11132543 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL184446 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113332305-B | Lipid composition of cytidine compound | 中国医学科学院医药生物技术研究所 | 2022-08-16 | — | — | CN | disclosed |
| CN-113336816-B | Cytidine compounds and anti-tumor application thereof | 中国医学科学院医药生物技术研究所 | 2022-05-17 | — | — | CN | disclosed |
| CN-112724088-B | Uracil compound and anti-tumor application thereof | 中国医学科学院医药生物技术研究所 | 2022-04-29 | — | — | CN | disclosed |
| CN-112724088-A | Uracil compound and anti-tumor application thereof | 中国医学科学院医药生物技术研究所 | 2021-04-30 | — | — | CN | disclosed |
| CN-112618550-A | Antineoplastic uracil compound and lipid composition thereof | 中国医学科学院医药生物技术研究所 | 2021-04-09 | — | — | CN | disclosed |
| US-6686462-B2 | Antiviral compounds and methods of administration | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-02-03 | — | — | US | disclosed |
| WO-1998038202-A1 | ANTIVIRAL PHOSPHONATE PRODRUGS OF NUCLEOSIDES AND NUCLEOSIDE ANALOGUES | DANA-FARBER CANCER INSTITUTE (US) | 1998-09-03 | — | — | WO | disclosed |
| EP-0044085-B1 | NOVEL NUCLEOSIDE DERIVATIVES | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-05-25 | — | — | EP | disclosed |
| US-4367332-A | N4 -Alkoxycarbonylarabinofuranosylcytosine | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1983-01-04 | — | — | US | disclosed |
| EP-0044085-A1 | Novel nucleoside derivatives | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-01-20 | — | — | EP | disclosed |